Inventor · disambiguated record
Sukeerthi Kumar
Also filed as: KUMAR SUKEERTHI
12 granted patents·1 pending application·44 citations·filing 2009–2018
88Inventor score
Files withGLENMARK PHARMACEUTICALS SA8KUMAR SUKEERTHI3CHAUDHARI SACHIN SUNDARLAL1KHAIRATKAR-JOSHI NEELIMA1
Top patents by PatentIndex Score
13 records- 0187US8507503B2Thienopyrimidinedione derivatives as TRPA1 modulatorsKUMAR SUKEERTHI·Filed 2010·Granted Aug 13, 2013·13 cites·31 claims
- 0282US8592398B22-amino-4-arylthiazole compounds as TRPA1 antagonistsKUMAR SUKEERTHI·Filed 2011·Granted Nov 26, 2013·8 cites·8 claims
- 0379US7951814B2Quinazolinedione derivatives as TRPA1 modulatorsGLENMARK PHARMACEUTICALS SA·Filed 2009·Granted May 31, 2011·4 cites·23 claims
- 0477US8575178B2Isothiazolo-pyrimidinedione derivatives as TRPA1 modulatorsKUMAR SUKEERTHI·Filed 2010·Granted Nov 5, 2013·5 cites·15 claims
- 0575US9186360B2Treatment of respiratory disorders using TRPA1 antagonistsKHAIRATKAR-JOSHI NEELIMA·Filed 2012·Granted Nov 17, 2015·6 cites·7 claims
- 0675US8623880B2Fused pyrimidine-dione derivatives as TRPA1 modulatorsCHAUDHARI SACHIN SUNDARLAL·Filed 2010·Granted Jan 7, 2014·6 cites·23 claims
- 0769US8987278B2Thienopyrimidinedione derivatives as TRPA1 modulatorsGLENMARK PHARMACEUTICALS SA·Filed 2013·Granted Mar 24, 2015·1 cites·29 claims
- 0865US9000159B2Fused pyrimidine-dione derivatives as TRPA1 modulatorsGLENMARK PHARMACEUTICALS SA·Filed 2013·Granted Apr 7, 2015·1 cites·16 claims
- 0954US9073955B22-amino-4-arylthiazole compounds as TRPA1 antagonistsGLENMARK PHARMACEUTICALS SA·Filed 2013·Granted Jul 7, 2015·0 cites·6 claims
- 1054US8889862B22-amino-4-arylthiazole compounds as TRPA1 antagonistsGLENMARK PHARMACEUTICALS SA·Filed 2013·Granted Nov 18, 2014·0 cites·6 claims
- 1153US9458173B2Amides of 2-amino-4-arylthiazole compounds and their saltsGLENMARK PHARMACEUTICALS SA·Filed 2013·Granted Oct 4, 2016·0 cites·28 claims
- 1249US9474758B2Thienopyrimidinedione derivatives as TRPA1 modulatorsGLENMARK PHARMACEUTICALS SA·Filed 2015·Granted Oct 25, 2016·0 cites·8 claims
- 1341US2020247800A1Substituted bicyclic heterocyclic compounds as nadph oxidase inhibitorsGLENMARK PHARMACEUTICALS SA·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sukeerthi Kumar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →